BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22965584)

  • 1. Ototopical neomycin exposure in children with nonintact tympanic membranes.
    Winterstein AG; Castillo JM; Xu D; Liu W; Antonelli PJ
    Laryngoscope; 2012 Nov; 122(11):2529-32. PubMed ID: 22965584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes.
    Winterstein AG; Liu W; Xu D; Antonelli PJ
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):277-83. PubMed ID: 23264116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone Ear Drops After Tympanostomy Tubes and the Risk of Eardrum Perforation: A Retrospective Cohort Study.
    Alrwisan A; Antonelli PJ; Winterstein AG
    Clin Infect Dis; 2017 Apr; 64(8):1052-1058. PubMed ID: 28329128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
    Poetker DM; Lindstrom DR; Patel NJ; Conley SF; Flanary VA; Link TR; Kerschner JE
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercial Quinolone Ear Drops Cause Perforations in Intact Rat Tympanic Membranes.
    Dirain CO; Karnani DN; Antonelli PJ
    Otol Neurotol; 2019 Dec; 40(10):1386-1391. PubMed ID: 31592822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in children with perforated tympanic membranes after tympanostomy tube placement: results using a pilot treatment algorithm.
    Schraff SA; Markham J; Welch C; Darrow DH; Derkay CS
    Am J Otolaryngol; 2006; 27(4):238-43. PubMed ID: 16798399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin otic solution: a review of its use in the management of ear infections.
    Simpson KL; Markham A
    Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane perforation healing.
    Buyten J; Kaufman G; Ryan M
    Otol Neurotol; 2007 Oct; 28(7):887-90. PubMed ID: 17955604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy.
    Fishman I; Sykes KJ; Horvat R; Selvarangan R; Newland J; Wei JL
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1025-9. PubMed ID: 21846926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of fluorescence to reveal middle ear penetration of quinolone drops.
    Whitaker GT; Collins WO; Antonelli PJ
    Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1232-5. PubMed ID: 22183903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results for use of single-flanged tympanostomy tubes in children.
    Knutsson J; von Unge M
    J Laryngol Otol; 2008 Jun; 122(6):584-9. PubMed ID: 17666133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of outcomes following tympanostomy tube placement or conservative measures for management of otitis media with effusion.
    Diacova S; McDonald TJ
    Ear Nose Throat J; 2007 Sep; 86(9):552-4. PubMed ID: 17970145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for Tympanic Membrane Perforation After Quinolone Ear Drops for Acute Otitis Externa.
    Wang X; Winterstein AG; Alrwisan A; Antonelli PJ
    Clin Infect Dis; 2020 Mar; 70(6):1103-1109. PubMed ID: 31044229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of quinolone and poloxamer otic suspension on rat tympanic membranes.
    Dirain CO; Antonelli PJ
    Int J Pediatr Otorhinolaryngol; 2021 Aug; 147():110805. PubMed ID: 34175658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.
    Antonelli PJ; Winterstein AG; Schultz GS
    Otol Neurotol; 2010 Apr; 31(3):519-23. PubMed ID: 20010446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of an ototopical preparation in a primate.
    Wright CG; Halama AR; Meyerhoff WL
    Am J Otol; 1987 Jan; 8(1):56-60. PubMed ID: 3031988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tympanic membrane perforation following ventilation tube removal in a pediatric setting: a historical study.
    Solomon PR; Lax MJ; Smitheringale AJ
    J Otolaryngol; 1993 Feb; 22(1):48-9. PubMed ID: 8445705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tympanic membrane changes in central tympanic membrane perforations.
    Oktay MF; Cureoglu S; Schachern PA; Paparella MM; Kariya S; Fukushima H
    Am J Otolaryngol; 2005; 26(6):393-7. PubMed ID: 16275408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.